Detalhe da pesquisa
1.
Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian Cancer.
Mol Pharm
; 18(9): 3464-3474, 2021 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34448393
2.
Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.
Br J Cancer
; 114(4): 417-26, 2016 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26882065
3.
Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma.
Cancers (Basel)
; 12(4)2020 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32260077
4.
CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of ß-catenin and E-cadherin.
Oncogene
; 39(1): 219-233, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31471585
5.
L1 Retrotransposon Heterogeneity in Ovarian Tumor Cell Evolution.
Cell Rep
; 23(13): 3730-3740, 2018 06 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29949758
6.
Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases.
Am J Cancer Res
; 7(11): 2257-2274, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29218249
7.
AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation.
Pathology
; 45(1): 49-54, 2013 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23222243